Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: Impact of HIV infection

L. Stewart Massad, Christopher B. Pierce, Howard Minkoff, D. Heather Watts, Teresa M. Darragh, Lorraine Sanchez-Keeland, Rodney L. Wright, Christine Colie, Gypsyamber D'Souza

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

To estimate the long term cumulative risk for cervical intraepithelial neoplasia grade 3 or worse after an abnormal cervical Pap test and to assess the effect of HIV infection on that risk. Participants in the Women's Interagency HIV Study were followed semiannually for up to 10 years. Pap tests were categorized according to the 1991 Bethesda system. Colposcopy was prescribed within 6 months of any abnormality. Risk for biopsy-confirmed CIN3 or worse after abnormal cytology and at least 12 months follow-up was assessed using Kaplan-Meier curves and compared using log-rank tests. Risk for CIN2 or worse was also assessed, since CIN2 is the threshold for treatment. After a median of 3 years of observation, 1,947 (85%) women subsequently presented for colposcopy (1,571 [81%] HIV seropositive, 376 [19%] seronegative). CIN2 or worse was found in 329 (21%) of HIV seropositive and 42 (11%) seronegative women. CIN3 or worse was found in 141 (9%) of seropositive and 22 (6%) seronegative women. In multivariable analysis, after controlling for cytology grade HIV seropositive women had an increased risk for CIN2 or worse (H.R. 1.66, 95% C.I 1.15, 2.45) but higher risk for CIN3 or worse did not reach significance (H.R. 1.33, 95% C.I. 0.79, 2.34). HIV seropositive women with abnormal Paps face a marginally increased and long-term risk for cervical disease compared to HIV seronegative women, but most women with ASCUS and LSIL Pap results do not develop CIN2 or worse despite years of observation. What's new? After an abnormal Pap test, what is the long term risk of developing cervical intraepithelial neoplasia, and how does HIV infection influence that risk? That's what the authors of this study set out to determine. They determined that HIV-positive women with HIV have only a slightly increased risk of developing CIN3 or worse after an abnormal Pap test over women without HIV. The risk of developing CINs did not plateau over time, however, meaning that a woman should remain vigilant for many years after an abnormal Pap result.

Original languageEnglish (US)
Pages (from-to)1854-1861
Number of pages8
JournalInternational Journal of Cancer
Volume134
Issue number8
DOIs
StatePublished - Apr 15 2014

Fingerprint

Cervical Intraepithelial Neoplasia
HIV Infections
Cell Biology
HIV
Incidence
Papanicolaou Test
Colposcopy
Observation

Keywords

  • cervical intraepithelial neoplasia
  • HIV in women
  • Pap test

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Massad, L. S., Pierce, C. B., Minkoff, H., Watts, D. H., Darragh, T. M., Sanchez-Keeland, L., ... D'Souza, G. (2014). Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: Impact of HIV infection. International Journal of Cancer, 134(8), 1854-1861. https://doi.org/10.1002/ijc.28523

Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology : Impact of HIV infection. / Massad, L. Stewart; Pierce, Christopher B.; Minkoff, Howard; Watts, D. Heather; Darragh, Teresa M.; Sanchez-Keeland, Lorraine; Wright, Rodney L.; Colie, Christine; D'Souza, Gypsyamber.

In: International Journal of Cancer, Vol. 134, No. 8, 15.04.2014, p. 1854-1861.

Research output: Contribution to journalArticle

Massad, LS, Pierce, CB, Minkoff, H, Watts, DH, Darragh, TM, Sanchez-Keeland, L, Wright, RL, Colie, C & D'Souza, G 2014, 'Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: Impact of HIV infection', International Journal of Cancer, vol. 134, no. 8, pp. 1854-1861. https://doi.org/10.1002/ijc.28523
Massad, L. Stewart ; Pierce, Christopher B. ; Minkoff, Howard ; Watts, D. Heather ; Darragh, Teresa M. ; Sanchez-Keeland, Lorraine ; Wright, Rodney L. ; Colie, Christine ; D'Souza, Gypsyamber. / Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology : Impact of HIV infection. In: International Journal of Cancer. 2014 ; Vol. 134, No. 8. pp. 1854-1861.
@article{f1df0cd4c17d4a218f49e037df9f7c54,
title = "Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: Impact of HIV infection",
abstract = "To estimate the long term cumulative risk for cervical intraepithelial neoplasia grade 3 or worse after an abnormal cervical Pap test and to assess the effect of HIV infection on that risk. Participants in the Women's Interagency HIV Study were followed semiannually for up to 10 years. Pap tests were categorized according to the 1991 Bethesda system. Colposcopy was prescribed within 6 months of any abnormality. Risk for biopsy-confirmed CIN3 or worse after abnormal cytology and at least 12 months follow-up was assessed using Kaplan-Meier curves and compared using log-rank tests. Risk for CIN2 or worse was also assessed, since CIN2 is the threshold for treatment. After a median of 3 years of observation, 1,947 (85{\%}) women subsequently presented for colposcopy (1,571 [81{\%}] HIV seropositive, 376 [19{\%}] seronegative). CIN2 or worse was found in 329 (21{\%}) of HIV seropositive and 42 (11{\%}) seronegative women. CIN3 or worse was found in 141 (9{\%}) of seropositive and 22 (6{\%}) seronegative women. In multivariable analysis, after controlling for cytology grade HIV seropositive women had an increased risk for CIN2 or worse (H.R. 1.66, 95{\%} C.I 1.15, 2.45) but higher risk for CIN3 or worse did not reach significance (H.R. 1.33, 95{\%} C.I. 0.79, 2.34). HIV seropositive women with abnormal Paps face a marginally increased and long-term risk for cervical disease compared to HIV seronegative women, but most women with ASCUS and LSIL Pap results do not develop CIN2 or worse despite years of observation. What's new? After an abnormal Pap test, what is the long term risk of developing cervical intraepithelial neoplasia, and how does HIV infection influence that risk? That's what the authors of this study set out to determine. They determined that HIV-positive women with HIV have only a slightly increased risk of developing CIN3 or worse after an abnormal Pap test over women without HIV. The risk of developing CINs did not plateau over time, however, meaning that a woman should remain vigilant for many years after an abnormal Pap result.",
keywords = "cervical intraepithelial neoplasia, HIV in women, Pap test",
author = "Massad, {L. Stewart} and Pierce, {Christopher B.} and Howard Minkoff and Watts, {D. Heather} and Darragh, {Teresa M.} and Lorraine Sanchez-Keeland and Wright, {Rodney L.} and Christine Colie and Gypsyamber D'Souza",
year = "2014",
month = "4",
day = "15",
doi = "10.1002/ijc.28523",
language = "English (US)",
volume = "134",
pages = "1854--1861",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology

T2 - Impact of HIV infection

AU - Massad, L. Stewart

AU - Pierce, Christopher B.

AU - Minkoff, Howard

AU - Watts, D. Heather

AU - Darragh, Teresa M.

AU - Sanchez-Keeland, Lorraine

AU - Wright, Rodney L.

AU - Colie, Christine

AU - D'Souza, Gypsyamber

PY - 2014/4/15

Y1 - 2014/4/15

N2 - To estimate the long term cumulative risk for cervical intraepithelial neoplasia grade 3 or worse after an abnormal cervical Pap test and to assess the effect of HIV infection on that risk. Participants in the Women's Interagency HIV Study were followed semiannually for up to 10 years. Pap tests were categorized according to the 1991 Bethesda system. Colposcopy was prescribed within 6 months of any abnormality. Risk for biopsy-confirmed CIN3 or worse after abnormal cytology and at least 12 months follow-up was assessed using Kaplan-Meier curves and compared using log-rank tests. Risk for CIN2 or worse was also assessed, since CIN2 is the threshold for treatment. After a median of 3 years of observation, 1,947 (85%) women subsequently presented for colposcopy (1,571 [81%] HIV seropositive, 376 [19%] seronegative). CIN2 or worse was found in 329 (21%) of HIV seropositive and 42 (11%) seronegative women. CIN3 or worse was found in 141 (9%) of seropositive and 22 (6%) seronegative women. In multivariable analysis, after controlling for cytology grade HIV seropositive women had an increased risk for CIN2 or worse (H.R. 1.66, 95% C.I 1.15, 2.45) but higher risk for CIN3 or worse did not reach significance (H.R. 1.33, 95% C.I. 0.79, 2.34). HIV seropositive women with abnormal Paps face a marginally increased and long-term risk for cervical disease compared to HIV seronegative women, but most women with ASCUS and LSIL Pap results do not develop CIN2 or worse despite years of observation. What's new? After an abnormal Pap test, what is the long term risk of developing cervical intraepithelial neoplasia, and how does HIV infection influence that risk? That's what the authors of this study set out to determine. They determined that HIV-positive women with HIV have only a slightly increased risk of developing CIN3 or worse after an abnormal Pap test over women without HIV. The risk of developing CINs did not plateau over time, however, meaning that a woman should remain vigilant for many years after an abnormal Pap result.

AB - To estimate the long term cumulative risk for cervical intraepithelial neoplasia grade 3 or worse after an abnormal cervical Pap test and to assess the effect of HIV infection on that risk. Participants in the Women's Interagency HIV Study were followed semiannually for up to 10 years. Pap tests were categorized according to the 1991 Bethesda system. Colposcopy was prescribed within 6 months of any abnormality. Risk for biopsy-confirmed CIN3 or worse after abnormal cytology and at least 12 months follow-up was assessed using Kaplan-Meier curves and compared using log-rank tests. Risk for CIN2 or worse was also assessed, since CIN2 is the threshold for treatment. After a median of 3 years of observation, 1,947 (85%) women subsequently presented for colposcopy (1,571 [81%] HIV seropositive, 376 [19%] seronegative). CIN2 or worse was found in 329 (21%) of HIV seropositive and 42 (11%) seronegative women. CIN3 or worse was found in 141 (9%) of seropositive and 22 (6%) seronegative women. In multivariable analysis, after controlling for cytology grade HIV seropositive women had an increased risk for CIN2 or worse (H.R. 1.66, 95% C.I 1.15, 2.45) but higher risk for CIN3 or worse did not reach significance (H.R. 1.33, 95% C.I. 0.79, 2.34). HIV seropositive women with abnormal Paps face a marginally increased and long-term risk for cervical disease compared to HIV seronegative women, but most women with ASCUS and LSIL Pap results do not develop CIN2 or worse despite years of observation. What's new? After an abnormal Pap test, what is the long term risk of developing cervical intraepithelial neoplasia, and how does HIV infection influence that risk? That's what the authors of this study set out to determine. They determined that HIV-positive women with HIV have only a slightly increased risk of developing CIN3 or worse after an abnormal Pap test over women without HIV. The risk of developing CINs did not plateau over time, however, meaning that a woman should remain vigilant for many years after an abnormal Pap result.

KW - cervical intraepithelial neoplasia

KW - HIV in women

KW - Pap test

UR - http://www.scopus.com/inward/record.url?scp=84893759056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893759056&partnerID=8YFLogxK

U2 - 10.1002/ijc.28523

DO - 10.1002/ijc.28523

M3 - Article

C2 - 24170366

AN - SCOPUS:84893759056

VL - 134

SP - 1854

EP - 1861

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -